uniQure (QURE) Operating Leases (2019 - 2026)
uniQure (QURE) recorded quarterly Operating Leases of $10.4 million in Q1 2026, up 5.66% quarter-over-quarter from $9.8 million in Q4 2025, and down 4.75% on a YoY basis from $10.9 million in Q1 2025.
uniQure (QURE) Operating Leases (2019 - 2026) Analysis & Trends
uniQure's Operating Leases history runs 8 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- In Q1 2026, Operating Leases fell 4.75% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 4.75% YoY), while the FY2025 annual figure was $9.8 million, down 33.28% from the prior year.
- Operating Leases was $10.4 million for Q1 2026 at uniQure, up from $9.8 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $40.1 million in Q4 2022 to a low of $9.8 million in Q4 2025.
- Historically, Operating Leases has averaged $21.5 million across 5 years, with a median of $27.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Operating Leases surged 38.34% in 2022, then plunged 59.58% in 2025.
- A 5-year view of Operating Leases shows it stood at $40.1 million in 2022, then declined by 29.39% to $28.3 million in 2023, then sank by 47.96% to $14.7 million in 2024, then tumbled by 33.28% to $9.8 million in 2025, then advanced by 5.66% to $10.4 million in 2026.
- The last three Operating Leases figures came in at $10.4 million (Q1 2026), $9.8 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.39 Mn |
| Dec 31, 2025 | 9.83 Mn |
| Sep 30, 2025 | 10.36 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 10.91 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 12.19 Mn |
| Jun 30, 2024 | 12.37 Mn |
| Mar 31, 2024 | 26.98 Mn |
| Dec 31, 2023 | 28.32 Mn |
| Sep 30, 2023 | 28.98 Mn |
| Jun 30, 2023 | 30.20 Mn |
| Mar 31, 2023 | 31.08 Mn |
| Dec 31, 2022 | 40.10 Mn |
| Sep 30, 2022 | 29.89 Mn |
| Jun 30, 2022 | 30.72 Mn |
| Mar 31, 2022 | 28.23 Mn |
| Dec 31, 2021 | 28.99 Mn |
| Sep 30, 2021 | 29.73 Mn |
| Jun 30, 2021 | 30.53 Mn |